CRISPR Therapeutics AG (CRSP)
NASDAQ: CRSP
· Real-Time Price · USD
58.56
-1.17 (-1.96%)
At close: Aug 18, 2025, 1:16 PM
-1.96% (1D)
| Bid | 42.55 |
| Market Cap | 5.33B |
| Revenue (ttm) | 37.36M |
| Net Income (ttm) | -467.8M |
| EPS (ttm) | -5.4 |
| PE Ratio (ttm) | -10.85 |
| Forward PE | -13.58 |
| Analyst | Buy |
| Ask | 74.47 |
| Volume | 1,241,379 |
| Avg. Volume (20D) | 3,297,293 |
| Open | 59.34 |
| Previous Close | 59.73 |
| Day's Range | 57.67 - 59.46 |
| 52-Week Range | 30.04 - 71.13 |
| Beta | 1.80 |
About CRSP
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol CRSP
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for CRSP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
CRISPR Therapeutics AG is scheduled to release its earnings on
Nov 4, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
-6.71%
CRISPR Therapeutics shares are trading lower follo...
Unlock content with
Pro Subscription
3 months ago
-11.86%
Shares of vaccine and gene therapy stocks are trading lower after FDA Commissioner Marty Makary reportedly named Vinay Prasad as director of the Center for Biologics and Research.
